Skip to main content

Table 1 Comparison the results of fluorescence in situ hybridization between groups

From: Generation of viable blastocysts from discarded human cleavage embryos

Variables

Groups

Chromosome aneuploidies

p value

OR

CI (95%)

Yes*

No*

Chr.13.Abn.

I

14 (34.1)

27 (65.9)

0.37

Base

 

II

9 (29.0)

22 (71.0)

1.49

(0.53–4.18)

III

5 (18.5)

22 (81.5)

2.28

(0.71–7.32)

Chr.18.Abn.

I

7 (17.1)

34 (82.9)

0.20

Base

 

II

9 (29.0)

22 (71.0)

0.50

(0.16–1.54)

III

3 (11)

24 (88.9)

1.64

(0.38–7.02)

Chr.21.Abn.

I

11 (26.8)

30 (73.2)

0.28

Base

 

II

6 (19.4)

25 (80.6)

1.52

(0.49–4.71)

III

3 (11.1)

24 (88.9)

2.93

(0.73–11.71)

Chr.X.Abn.

I

5 (12.2)

36 (87.8)

0.74

Base

 

II

4 (12.9)

27 (87.1)

0.93

(0.23–3.82)

III

5 (18.5)

22 (81.5)

0.61

(0.15–2.35)

Chr.Y.Abn.

I

6 (14.6)

35 (85.4)

0.35

Base

 

II

4 (12.9)

27 (87.1)

1.15

(0.29–4.51)

III

1 (3.7)

26 (96.3)

4.45

(0.50–39.31)

Autosom.Abn.

I

14 (34.1)

27 (65.9)

0.28

Base

 

II

17 (54.8)

4 (45.2)

0.42

(0.16–1.11)

III

8 (26.6)

19 (70.4)

1.23

(0.43–3.51)

Sex.Abn.

I

10 (24.4)

31 (75.6)

0.88

Base

 

II

6 (19.4)

25 (80.6)

0.88

(0.27–2.80)

III

6 (22.2)

21 (77.8)

1.19

(0.33–4.24)

Total.Abn.

I

18 (43.9)

23 (56.1)

0.28

Base

 

II

19 (61.3)

12 (38.7)

0.49

(0.19–1.27)

III

12 (44.4)

15 (55.6)

0.97

(0.36–2.60)

Mosaicism

II

8 (25.8)

23 (74.2)

0.28

Base

 

1.05

(0.36–3.04)

III

10 (37.0)

17 (63.0)

0.62

(0.22–1.76)

  1. *Data are presented as total numbers of each variable (percentage). All values between the groups were presented as not significant (p ≥ 0.05)
  2. Chr chromosome, Abn. abnormality
  3. Group I (n = 41), defined as good quality embryos at cleavage stage, group II (n = 31), defined as surplus embryos at cleavage stage, and group III (n = 27), defined as surplus embryos at blastocyst stage